Related Experiment Videos
[Neurotrophin therapy. Some bioethical considerations]
T Serrano-Sánchez1, I Díaz-Armesto
1Centro Internacional de Restauracion Neurologica (CIREN), La Habana, Cuba. teresa@neubas.sld.cu
Revista De Neurologia
|October 29, 2002
Summary
This study examines ethical considerations in human research, particularly for fatal diseases like Alzheimer's. It analyzes the benefit/risk ratio of interventions such as neurotrophic factor (NGF) therapy.
Area of Science:
- Bioethics
- Neuroscience
- Medical Ethics
Context:
- Public health and biomedical research necessitate ethical frameworks.
- Human research aims to cure or improve quality of life for patients with fatal diseases.
- Balancing potential benefits against risks is crucial in medical interventions.
Purpose:
- To analyze ethical considerations in human research.
- To evaluate the benefit/risk ratio of interventions for fatal diseases.
- To discuss the potential of neurotrophic factor (NGF) therapy for Alzheimer's disease.
Summary:
- Examines ethical aspects of human research, focusing on fatal diseases.
- Discusses the benefit/risk assessment for medical interventions.
- Explores neurotrophic factor (NGF) therapy for Alzheimer's disease, emphasizing careful research stages.
Impact:
- Highlights the need for a new ethical culture to regulate life interventions.
- Ensures the primacy of human well-being for present and future generations.
- Promotes responsible advancement in biomedical research and patient care.